
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.430 | 2.430 | 0.000 |
Shares | 94.330 | 94.330 | 0.000 |
Other | 3.250 | 3.250 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 31.944 | 18.836 |
Price to Book | 3.804 | 2.491 |
Price to Sales | 3.049 | 1.688 |
Price to Cash Flow | 18.481 | 10.517 |
Dividend Yield | 0.152 | 1.031 |
5 Years Earnings Growth | 10.965 | 11.800 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 35.680 | 15.403 |
Industrials | 28.450 | 21.269 |
Technology | 23.360 | 19.794 |
Financial Services | 6.060 | 13.488 |
Consumer Cyclical | 4.810 | 11.939 |
Utilities | 1.640 | 2.435 |
Number of long holdings: 51
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Guidewire | US40171V1008 | 5.82 | 230.38 | +1.16% | |
Natera Inc | US6323071042 | 4.46 | 161.76 | +0.12% | |
GeneDx Holdings Corp Ordinary Shares - Class A | - | 4.35 | - | - | |
RBC Bearings | US75524B1044 | 4.23 | 388.59 | +1.43% | |
Repligen | US7599161095 | 3.35 | 127.47 | +0.40% | |
FTAI Aviation | KYG3730V1059 | 3.30 | 114.95 | +1.60% | |
Impulse Dynamics Ireland Series F-3 | - | 3.25 | - | - | |
Q2 Holdings | US74736L1098 | 3.15 | 94.59 | +2.48% | |
BioLife Solutions | US09062W2044 | 3.07 | 22.84 | +0.40% | |
Federal Signal | US3138551086 | 3.03 | 110.79 | +1.33% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Alger S The Alger American Asset Gi | 580.3M | 5.27 | 24.52 | 14.90 | ||
Alger S The Alger American Asset i2 | 580.3M | -8.32 | 17.79 | 14.01 | ||
Alger S The Alger American Asset G3 | 580.3M | -8.38 | 17.45 | 13.64 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review